Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score33
United States Fiscal year ends December CIK 0001356576 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Georges Gemayel
23 Feb 2026
Director
Exercised, kept
15,000
$12.98
$194.70K
Frederick M. Hudson
9 Jan 2026
Director
Exercised, kept
15,000
$12.98
$194.70K
Charles W Newhall III
21 Nov 2025
Director
Exercised, kept
15,000
$12.98
$194.70K

What was left out

Form 4 filings counted 66
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 12
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 2,909,472
History held since 7 May 2012